Ligand validation:3CA3

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3CA3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3CA3_NAG_A_266	11%	41%	0.277	0.791	0.8	1.46	-	4	0	0	100%	0.9333
3CA6_NAG_A_266	13%	49%	0.27	0.806	0.66	1.29	-	2	0	0	100%	0.9333
3CA5_NAG_A_266	8%	38%	0.297	0.773	0.64	1.77	-	3	0	0	100%	0.9333
3CA1_NAG_A_266	7%	44%	0.306	0.752	0.69	1.44	-	4	0	0	100%	0.9333
3CA4_NAG_A_266	6%	28%	0.291	0.731	0.8	2.03	-	7	0	0	100%	0.9333
3CAH_NAG_A_266	6%	43%	0.299	0.731	0.58	1.61	-	3	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
4AKM_NAG_A_1379	100%	67%	0.029	0.994	0.54	0.73	-	-	0	0	100%	0.9333
3RIK_NAG_D_509	100%	8%	0.035	0.991	2.03	2.54	4	7	2	0	100%	0.9333
5VEM_NAG_B_509	100%	74%	0.003	0.957	0.46	0.56	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.